Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  AmerisourceBergen Corp.    ABC

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/21/2017 06/22/2017 06/23/2017 06/26/2017 06/27/2017 Date
95.62(c) 96.37(c) 95.82(c) 95.99(c) 95.53(c) Last
1 092 668 1 730 046 1 624 071 1 171 116 1 253 124 Volume
+2.54% +0.78% -0.57% +0.18% -0.48% Change
More quotes
Financials ($)
Sales 2017 155 194 M
EBIT 2017 2 041 M
Net income 2017 1 183 M
Debt 2017 401 M
Yield 2017 1,49%
Sales 2018 168 630 M
EBIT 2018 2 160 M
Net income 2018 1 246 M
Finance 2018 19,3 M
Yield 2018 1,59%
P/E ratio 2017 17,76
P/E ratio 2018 16,54
EV / Sales2017 0,14x
EV / Sales2018 0,12x
Capitalization 20 860 M
More Financials
Company
AmerisourceBergen Corp. is a pharmaceutical sourcing and distribution services company.It serves as a healthcare, pharmaceutical and biotech manufacturers to improve patient access to products and enhance patient care.The company operates through two segments: Pharmaceutical Distribution and... 
Sector
Drug Retailers
Calendar
07/27Earnings Release
More about the company
Surperformance© ratings of AmerisourceBergen Corp.
Trading Rating : Investor Rating :
More Ratings
Latest news on AMERISOURCEBERGEN CORP.
06/27 AMERISOURCEBERGEN : Besse Medical, a part of AmerisourceBergen, Broadens Invent...
06/24 AMERISOURCEBERGEN : CPPA Accredits US Bioservices, a Part of AmerisourceBergen, ..
06/24 AMERISOURCEBERGEN : CPPA Accredits US Bioservices, a part of AmerisourceBergen, ..
06/23 AMERISOURCEBERGEN : CPPA Accredits US Bioservices, a part of AmerisourceBergen, ..
06/22 AMERISOURCEBERGEN CORP : Change in Directors or Principal Officers (form 8-K)
06/22 AMERISOURCEBERGEN CORPORATION (NYSE : ABC) Files An 8-K Departure of Directors o..
06/19 AMERISOURCEBERGEN CORP : Regulation FD Disclosure, Financial Statements and Exhi..
06/19 AMERISOURCEBERGEN : Structures Operating Model and Executive L...
06/19 AMERISOURCEBERGEN : Structures Operating Model and Executive Leadership Team to ..
05/31 AMERISOURCEBERGEN : Stephen A. Hendrickson Joins AlliantRx as Chief Executive Of..
More news
Sector news : Drug Retailers - NEC
06/22DJWALGREENS BOOTS ALLIANCE : Theranos, Walgreens to Settle -- WSJ
06/21DJWALGREENS BOOTS ALLIANCE : Theranos, Walgreens Reach Deal to Settle Lawsuit--Upd..
06/21 STADA ARZNEIMITTEL : Low acceptances leave Stada bid down to the wire
06/21DJWALGREENS BOOTS ALLIANCE : Theranos, Walgreens Reach Deal to Settle Lawsuit
06/20 U.S. Supreme Court again limits where companies can be sued
More sector news : Drug Retailers - NEC
4-Traders Strategies on AMERISOURCEBERGEN CORP. 
2016In an oversold condition
2014A steady bullish trend
More Strategies
Latest Tweets
12:40pSomewhat Positive Press Coverage Somewhat Likely to Impact AmerisourceBergen .. 
05:30a$39.32 Billion in Sales Expected for AmerisourceBergen Corporation $Holding C.. 
06/27AmerisourceBergen : Besse Medical, a part of AmerisourceBergen, Broadens Inve.. 
06/27Besse Medical :, a Part of AmerisourceBergen, Broadens Inventory Management P.. 
06/27Abcam Plc initiated by Berenberg Bank at buy. GBX 1,100 PT.  
More tweets
Qtime:73
News from SeekingAlpha
06/26 THE OPIOID ABUSE EPIDEMIC : What's The Investment Angle?
06/19 AmerisourceBergen announces new organizational structure
06/12 VALUATION DASHBOARD : Healthcare - Update
06/06 Fred's weak Q1 and potential entry of Amazon weighs on drug distributors
06/05 Drug Distributors Revisited
Advertisement
Chart AMERISOURCEBERGEN CORP.
Duration : Period :
AmerisourceBergen Corp. Technical Analysis Chart | ABC | US03073E1055 | 4-Traders
Full-screen chart
Technical analysis trends AMERISOURCEBERGEN...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 93,1 $
Spread / Average Target -2,6%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Steven H. Collis Chairman, President & Chief Executive Officer
Tim G. Guttman Chief Financial Officer & Executive Vice President
Dale B. Danilewitz Chief Information Officer & Executive VP
Henry Wadsworth McGee Independent Director
Jane Ellen Henney Lead Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
AMERISOURCEBERGEN CORP..22.18%20 860
WALGREENS BOOTS ALLIAN..-6.65%83 514
CVS HEALTH2.00%82 003
EXPRESS SCRIPTS HOLDIN..-6.06%38 792
MCKESSON CORPORATION18.68%35 248
CARDINAL HEALTH INC10.12%25 034
More Results